Nachrichten zur Amicus Therapeutics Inc. Aktie

Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -10% and 0.13%, respectively, for the quarter ended December 2024. Do…

Besides Wall Streets top -and-bottom-line estimates for Amicus Therapeutics (FOLD), review projections for some of its key metrics to gain…

Amicus Therapeutics (FOLD) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President…

…

PRINCETON, N.J., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will…

Amicus Therapeutics (FOLD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…

PRINCETON, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate…

PRINCETON, N.J., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate…

…

…

…

…

Earnings call: Amicus Therapeutics highlights solid Q1 growth, raises guidance…

…

…